Clinical trials
Completed Phase 1 Hematologic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
128 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 6 |
| 2008 | 9 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 12 |
| 2012 | 7 |
| 2013 | 7 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 9 |
| 2021 | 10 |
| 2022 | 3 |
| 2023 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 128 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 7 |
| National Cancer Institute (NCI) | 6 |
| Celgene | 4 |
| Acrotech Biopharma Inc. | 3 |
| Amgen | 3 |
| Jazz Pharmaceuticals | 3 |
| Millennium Pharmaceuticals, Inc. | 3 |
| St. Jude Children's Research Hospital | 3 |
| AbbVie | 2 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 128 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 22 |
| Lymphoma | 21 |
| Leukemia | 18 |
| Leukemia, Myeloid, Acute | 18 |
| Neoplasms | 17 |
| Lymphoma, Non-Hodgkin | 16 |
| Multiple Myeloma | 16 |
| Myelodysplastic Syndromes | 16 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 14 |
Trials
Showing 1 to 25 of 128. Each trial links to its page on Pharma Observatory.
28 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.